-Live Mint Strong political commitment is needed to build a system of universal health coverage and better regulations Life expectancy in India has more than doubled since independence, to 65 years, from just 32 in 1950. The infant mortality rate has been cut by two-thirds since 1971. Smallpox and guinea worm have been eradicated, the spread of HIV/AIDS has been contained, and the World Health Organization has declared India polio-free. Yet for all...
More »SEARCH RESULT
Total Matching Records found : 17
Indians booed at global meet for ‘genocide of TB patients’ -Malathy Iyer
-The Times of India PARIS: Accusing India of committing genocide of tuberculosis patients, international activists on Friday booed Indian health officials at the ongoing Union World Conference on Lung Health here while they were trying to showcase the country's efforts to check the disease that kills 1,000 Indians every day. "India supplies drugs to the world, but it's not providing anti-TB drugs to its own patients," said Kenyan activist Bactrin Killingo, who...
More »Ranbaxy drugs fine, say WHO and UK regulator -Rema Nagarajan
-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...
More »SC ‘very serious’ tag on Ranbaxy charges-R Balaji
-The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material". The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening...
More »Hospitals, chemists to wait for regulatory word on Ranbaxy
-PTI Drug regulator DGCI is conducting a "focussed scrutiny" of medicines sold by Ranbaxy and some other drug makers, but says it remains confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products. While the company continues to assert that its drugs meet all regulatory standards, a few hospitals and pharmacies have adopted a cautious stand on use of its products. However, a majority...
More »
